药物洗脱支架植入术后12个月内手术相关风险
研究纳入2005至2012年丹麦西部22,590例药物洗脱支架经皮冠状动脉介入(DES-PCI)患者,其中4,303例后续接受手术,与20,232例无缺血性心脏病(IHD)的同类手术患者对照。DES-PCI组术后30天心肌梗死(MI)和心源性死亡风险升高,全因死亡率无显著差异;按PCI至手术时间分层,仅术后第一个月内手术风险显著升高。
要点
- DES-PCI后12个月内手术者MI风险1.6% vs 无IHD对照0.2%,OR 4.82(95%CI 3.25-7.16)。
- DES-PCI后12个月内手术者心源性死亡1.0% vs 对照0.2%,OR 5.87(95%CI 3.60-9.58)。
- 全因死亡率3.1% vs 2.7%,OR 1.12(95%CI 0.91-1.38),无显著差异。
核心结论
- DES-PCI后12个月内需手术者与无IHD手术患者相比,MI和心源性死亡风险升高,风险仅见于DES-PCI后第一个月内,提示手术或可早于现行推荐时间进行。
研究设计与样本
- 2005至2012年丹麦西部登记研究,22,590例DES-PCI患者中4,303例后续手术,与20,232例无IHD同类手术患者对照,记录链接西部丹麦心脏登记与丹麦国家患者登记。
主要发现
- DES-PCI组术后30天MI 1.6% vs 无IHD对照0.2%,OR 4.82(95%CI 3.25-7.16)。
- DES-PCI组术后30天心源性死亡1.0% vs 对照0.2%,OR 5.87(95%CI 3.60-9.58)。
- DES-PCI组术后30天全因死亡3.1% vs 对照2.7%,OR 1.12(95%CI 0.91-1.38),无显著差异。
- 按PCI至手术时间分层,仅DES-PCI后第一个月内手术与事件风险显著升高相关。
关键数值与推荐
- 指南推荐DES-PCI后至少6个月再行手术。
- DES-PCI后12个月内手术者MI风险OR 4.82(95%CI 3.25-7.16),心源性死亡OR 5.87(95%CI 3.60-9.58)。
临床怎么用
- 原文结论提示DES-PCI后手术或可早于现行推荐的6个月进行,风险升高仅见于DES-PCI后第一个月内。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guidelines recommend postponing surgery for at least 6 months after treatment with a drug-eluting stent by percutaneous coronary intervention (DES-PCI). OBJECTIVES: The goal of this study was to evaluate the surgical risk associated with DES-PCI compared with that in nonstented patients without ischemic heart disease (IHD). METHODS: Between 2005 and 2012, a total of 22,590 patients underwent DES-PCI in western Denmark. By record-linking the Western Denmark Heart Registry and the Danish National Patient Register, we evaluated 4,303 DES-PCI-treated patients with a surgical procedure and compared them with a control group of patients without previous IHD undergoing similar surgical procedures (n = 20,232). Events of interest were myocardial infarction (MI), cardiac death, and all-cause mortality within 30 days after surgery. RESULTS: Surgery in DES-PCI-treated patients was associated with an increased risk of MI (1.6% vs. 0.2%; odds ratio [OR]: 4.82; 95% confidence interval [CI]: 3.25 to 7.16) and cardiac death (1.0% vs. 0.2%; OR: 5.87; 95% CI: 3.60 to 9.58) but not all-cause mortality (3.1% vs. 2.7%; OR: 1.12; 95% CI: 0.91 to 1.38). When stratified for time from PCI to surgery, only surgery within the first month was associated with a significant increased risk of events. CONCLUSIONS: Patients requiring surgery within 12 months after DES-PCI had an increased risk of MI and cardiac death compared with patients without IHD. The increased risk was only present within the first month after DES-PCI, suggesting that surgery might be undertaken earlier than currently recommended.
引用
- Egholm G, Kristensen SD, Thim T, et al. Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation. J Am Coll Cardiol. 2016. PMID: 27978946. doi:10.1016/j.jacc.2016.09.967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。